000			01997 a2200577 4500
005			20250516182901.0
264		0	_c20141020
008			201410s 0 0 eng d
022			_a1365-2559
024	7		_a10.1111/his.12277 _2doi
040			_aNLM _beng _cNLM
100	1		_aTsuzuki, Toyonori
245	0	0	_aTyrosine kinase inhibitor-induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism. _h[electronic resource]
260			_bHistopathology _cMar 2014
300			_a484-93 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinoma, Renal Cell _xblood supply
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aKidney Neoplasms _xblood supply
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNeovascularization, Pathologic _xdrug therapy
650	0	4	_aNephrectomy
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds _xtherapeutic use
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors
650	0	4	_aRetrospective Studies
650	0	4	_aSorafenib
650	0	4	_aSunitinib
700	1		_aSassa, Naoto
700	1		_aShimoyama, Yoshie
700	1		_aMorikawa, Takamitsu
700	1		_aShiroki, Ryoichi
700	1		_aKuroda, Makoto
700	1		_aFukatsu, Akitoshi
700	1		_aKuwahara, Kyoko
700	1		_aYoshino, Yasushi
700	1		_aHattori, Ryohei
700	1		_aGotoh, Momokazu
773	0		_tHistopathology _gvol. 64 _gno. 4 _gp. 484-93
856	4	0	_uhttps://doi.org/10.1111/his.12277 _zAvailable from publisher's website
999			_c23306579 _d23306579